1.
Clin Case Rep
; 9(7): e04464, 2021 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34295486
RESUMO
We can infer that the immunostimulatory effect of nivolumab and reactivation of cetuximab enhance the antitumor effect of the therapy.